+86 754 3992 3979
Henry Zheng firstname.lastname@example.org
Sam Lee email@example.com
WhatsApp +86 139 2399 1891
StatesMale Medicine Series
Treat PE (Premature Ejaculation) and ED (Erectile Dysfunction)
Traditional Chinese Medicine Series
More than 20 years of experience
External Medicine Series
Applies to Everybody
Medical Consumables Series
Seriously Recommended by 2000+ Hospitals
Established in 1999, Guangdong Taienkang Pharmaceutical Co., Ltd. (hereinafter referred to as "Taienkang") has 8 wholly-owned subsidiaries. It has a marketing network and sales force covering 28 provincial regions, 2,000+ hospitals, and 200,000 pharmacies.
At the beginning of Taienkang’s establishment, it established the development route of pharmaceutical marketing, which means dedicated to the intensive promotion and marketing of carefully selected domestic and foreign medical characteristics and competitiveness pharmaceutical products, providing one-stop services from market demand analysis, marketing strategy planning, product sales, channel expansion to terminal management, customer relationship maintenance, etc... The enterprise acted as the agent who has successfully operated products such as "Fishing Pill IV", "Jolethin"(Iodized Lecithin Tablets), "Po Sum On Medicated Oil" (Peppermint Surface Oil) and American "Johnson & Johnson" Medical Devices, independently produced "Wuhuan" characteristic external medicine series, exclusive patent varieties "Compound Black Chicken Pill", "Tianfukang" series pills and "Taienkang" medical supplies are popular among by the market. During the global epidemic outbreak of COVID-19 in 2020, the disposable medical (surgical) masks produced by the enterprise are sold abroad while ensuring the domestic epidemic prevention supply. Taienkang has gradually established core advantages in the field of pharmaceutical marketing.
In the competitive pharmaceutical industry economic environment, the enterprise explores the innovation of marketing business model actively, and increasing the strength in the field of production and R&D constantly to improve the core technology of products through the innovative production process, set the R&D strategy with "Innovative drug" as "the Top", "Improved new drugs and biotechnology platform" as "the Body", "Generic drugs" as "the Base", which are the solid backing for the enterprise to conduct independent R&D and enhance core competitiveness. Taienkang fully implements the development concept of "One main line, Going out, Bring in", following the national "Belt and Road" strategy to expand foreign markets, introduces foreign advantages and brand products into the Chinese market, lead the advantageous product of the enterprise to the foreign market, continues the original business advantages and market competitiveness of the enterprise.
In the future, Taienkang will always adhere to the enterprise concept of "Honesty, Enterprising and True Feelings", and insist on taking public health as its duty, taking innovation and research as the core development. Relying on a perfect marketing network, excellent products, top R&D team, Taienkang will enrich and perfect the company’s product system, and rapidly realize the scale production through a technology industrialization platform and pharmaceutical production base. Therefore, the enterprise could improve its core competitiveness in the market, promote the comprehensive pharmaceutical enterprise construction on the whole industry chain of "Research, Production and Marketing", cooperate with its partners for a win-win, create more public welfare values for the society, bring more health products to customers, striving for its grand goal of health business!